Skip to main content
Clinical Trials/NCT06342843
NCT06342843
Recruiting
Not Applicable

Direct Superior Approach Versus PosteroLateral Approach in Total Hip Arthroplasty: a Multicenter Double Blinded Randomized Controlled Trial

Isala3 sites in 1 country211 target enrollmentMarch 26, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis, Hip
Sponsor
Isala
Enrollment
211
Locations
3
Primary Endpoint
Hip disability and Osteoarthritis Outcome Score - Physical Function Short Form
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

This study will compare postoperative pain, health related quality of life (HRQoL), function, rehabilitation, urinary incontinence, muscle atrophy and component positioning in total hip arthroplasty (THA) using the posterolateral approach (PLA) or the direct superior approach (DSA). In addition, the CT images will be used to validate a new metal artefact reduction technique.

Detailed Description

Objective: The primary objective is to evaluate health related quality of life (HRQoL) after THA using the DSA compared to the golden standard PLA in patients with incapacitating hip osteoarthritis after two weeks. The secondary objectives are divided into 1) long-term HRQoL evaluation, 2) physical performance, 3) radiologic muscle atrophy and component placement of the THA, 4) validation of a new metal artifact reduction technique for CT, and 5) relationship urinary incontinence and muscle atrophy. Study design: Multicenter, prospective, double blinded, randomized controlled intervention study in which the used operation method is not shared with the patient until one year after surgery and in which the study researcher is also blinded. Study population: A total of 211 men and women, age ≥ 18 years, with symptomatic hip osteoarthritis in whom THA is indicated. Intervention (if applicable): For this randomized controlled trial (RCT), patients will be randomly allocated in one of two groups: one group receives THA by using PLA, the other group receives THA by using DSA. Main study parameters/endpoints: As primary outcome specifically the Hip Disability and Osteoarthritis Outcome Score- Physical Function Short Form (HOOS-PS) is used for the short-term HRQoL. Secondary parameters/endpoints are split up into different categories. 1) HRQoL evaluation on the long term using patient reported outcome measures (PROMs) (NRS score, Short form-12 (SF-12), HOOS subscales, Global rating of change, and Euro Quality of Life questionnaire). 2) Physical function using physical functioning test (Timed Up and Go test, 40-meter self-paced walk test for hip osteoarthritis and Stair Climb Test). 3) Muscle atrophy measurements using CT scans. Muscle atrophy is expressed in both quantity of muscle volume loss and extend of fatty infiltration using the Goutallier scale. Component placement is measured in different angles. 4) Evaluation of a new metal artifact reduction technique for CT images. 5) Relationship between muscle atrophy and urinary incontinence after total hip replacement. Other study parameters include preoperative demographics such as age and gender, perioperative data such as blood loss, use of analgetics, operation time and postoperative complications such as infection, aseptic loosening and dislocation.

Registry
clinicaltrials.gov
Start Date
March 26, 2024
End Date
December 31, 2027
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Isala
Responsible Party
Principal Investigator
Principal Investigator

Roelina Munnik, PhD

Researcher

Isala

Eligibility Criteria

Inclusion Criteria

  • Has symptomatic incapacitating coxarthrosis in whom total hip arthroplasty (THA) is indicated, diagnosed by both physical examination and pelvic/hip X-ray
  • Has signed informed consent
  • Is ageing 18 years or older at time of study entry
  • Is competent and able to participate in follow-up

Exclusion Criteria

  • Previous ipsilateral hip surgery
  • BMI \>35 kg/m2
  • Contralateral incapacitating coxarthrosis, diagnosed by both physical examination and pelvic/hip X-ray
  • Neurological conditions influencing walking pattern
  • Inability to walk without walking aid preoperatively
  • Rheumatoid arthritis (RA)
  • Severe hip dysplasia
  • Cognitive impairment
  • Malignancies or metastases involving the hip joint or the nearby soft tissues
  • Inability to speak and write Dutch language

Outcomes

Primary Outcomes

Hip disability and Osteoarthritis Outcome Score - Physical Function Short Form

Time Frame: pre-operatively and 2 weeks, 6 weeks, 3months and 12 months postoperatively

Evaluation symptoms and shortcomings in patients with hip complaints, 0-100 points, in which a higher score indicates less complaints

Secondary Outcomes

  • Numeric Rating Scale (NRS)(pre-operatively and 2 weeks, 6 weeks, 3 months and 12 months postoperatively)
  • Short Form-12 (SF-12)(pre-operatively and 2 weeks, 6 weeks and 12 months postoperatively)
  • Hip disability and Osteoarthritis Outcome Score (HOOS)(pre-operatively and 2 weeks, 6 weeks and 12 months postoperatively)
  • Euro Quality of Life (EQ-5D)(pre-operatively and 2 weeks, 6 weeks, 3 months and 12 months postoperatively)
  • Global Rating of Change scale(pre-operatively and 2 weeks, 6 weeks, 3 months and 12 months postoperatively)
  • Timed Up and Go test (TUG test)(pre-operatively and 2 weeks, 6 weeks and 12 months postoperatively)
  • 40 meter self-paced walk test for hip osteoarthritis(pre-operatively and 2 weeks, 6 weeks and 12 months postoperatively)
  • Stair climb test(pre-operatively and 2 weeks, 6 weeks and 12 months postoperatively)
  • Muscle atrophy by using Computer Tomography (CT) scanner(pre-operatively and 12 months postoperatively)
  • Computer Tomography (CT) image with orthopedic metal artefact reduction (O-MAR)(pre-operatively and 12 months postoperatively)
  • image diagnostic confidence(pre- operatively and 12 months postoperatively)
  • Incontinence Severity Index (ISI)(pre-operatively and 6 weeks and 12 months postoperatively)
  • Incontinence Impact Questionnaire Short Form (IIQ-7)(pre-operatively and 6 weeks and 12 months postoperatively)
  • Postoperative cup position on Computer Tomography (CT) image(12 months postoperatively)
  • Comparing definite cup position with preoperative planned cup position(pre- operatively and 12 months postoperatively)
  • Comparing definite component position with surgeon's perioperative estimation of component position(direct postoperative and 12 months postoperatively)
  • overall image quality(pre- operatively and 12 months postoperatively)
  • metal artifacts on images(pre- operatively and 12 months postoperatively)
  • Urinary Distress Inventory, Short Form (UDI-6)(pre-operatively and 6 weeks and 12 months postoperatively)
  • Patient Global Impression of Severity (PGIS)(pre-operatively and 6 weeks and 12 months postoperatively)
  • Incontinence after Total Hip Arthroplasty(6 weeks and 12 months postoperatively)

Study Sites (3)

Loading locations...

Similar Trials